Celltrion
068270.KS
#754
Rank
NZ$45.04 B
Marketcap
$217.49
Share price
0.72%
Change (1 day)
6.46%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : NZ$2.69 Billion

According to Celltrion 's latest financial reports the company's total debt is NZ$2.69 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31NZ$0.98 B8.07%
2021-12-31NZ$0.91 B-7.29%
2020-12-31NZ$0.98 B55.31%
2019-12-31NZ$0.63 B-7.8%
2018-12-31NZ$0.68 B-18.51%
2017-12-31NZ$0.84 B4.11%
2016-12-31NZ$0.81 B-17.81%
2015-12-31NZ$0.98 B0.42%
2014-12-31NZ$0.98 B13.89%
2013-12-31NZ$0.86 B23.32%
2012-12-31NZ$0.70 B52.26%
2011-12-31NZ$0.46 B45.67%
2010-12-31NZ$0.31 B6.34%
2009-12-31NZ$0.29 B-7.57%
2008-12-31NZ$0.32 B737.37%
2007-12-31NZ$38.42 M